Clinical Trials Highlighted at the AACR Annual Meeting 2015
This year, at the AACR Annual Meeting held in Philadelphia April 18 to 22, an astounding 19,300 members of...
This year, at the AACR Annual Meeting held in Philadelphia April 18 to 22, an astounding 19,300 members of...
Game-changing modern cancer therapies—immunotherapies and targeted therapies, among others—have been providing promising treatment outcomes in the recent years. The...
Guest Post by Toni Kay Mangskau Mayo Clinic Cancer Center
A string of innovative clinical trials designed to accelerate the pace at which personalized cancer medicines are developed have...
With the late-breaking and clinical trial-placeholder abstract deadlines a week away, we thought it was a good time to...
Adding the PI3-kinase inhibitor pictilisib to fulvestrant doubled progression-free survival for some women with advanced hormone-receptor positive breast cancer,...
After making great strides for some patients with melanoma and lung cancer, immunotherapy drugs are starting to offer hope...
Lung cancer awareness month started hot on the heels of two exciting pieces of news that highlight the promise...
The signature pink ribbons of Breast Cancer Awareness Month have become almost as much a part of October as...
Each year, nearly 20,000 people in the United States are diagnosed with lung adenocarcinomas that harbor EGFR mutations. While...